Previous Page
Suniva, Inc., a US manufacturer of high-efficiency crystalline silicon solar cells and modules, announced its partnership with AEE Solar, one of the nation’s largest wholesale distributors of high-quality solar products and equipment.
Taiwan Semiconductor Manufacturing Co., Ltd. (TSMC) has joined IMS Nanofabrication’s multibeam mask writer development collaboration, adding its support to that of collaboration founding members Dai Nippon Printing Co., Ltd. (DNP), In- tel Corporation and Photronics Inc. The purpose of the collaborative program is to develop an electron multi-beam mask writer for use in advanced mask lithography applications with the goal of meeting lithography specifications below 10nm while achieving high throughput requirements. The program is nearing the completion of a proof-of-concept phase, and the upcoming phase of the collaboration will focus on the design and construction of an alpha and beta version of the multi-beam mask writer.
http://www.ims.co.at http://www.dnp.co.jp/eng/
Worcestershire-based Teer Coatings in UK has been awarded funding as part of a Nanotechnology Knowledge Transfer Network initiative. The firm have secured over £750,000 in funding with support, as part of SuperREACT, a project to develop technologies which can upgrade research tools into production equipment for the cluster technology market. Along with science and technology firm, Johnson Matthey, Teer will work with the University of Birmingham as an academic partner. Teer Coatings Ltd has developed new fouling resistant coatings using PACVD and hybrid PVD-PACVD processes. The Company was formed in 1985.
http://www.teercoatings.co.uk/
Tegal Corporation (NASDAQ: TGAL) announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine. Tegal will issue 236,433 shares of common stock, representing 14% of Tegal’s total shares outstanding prior to the closing, to former CollabRx stockholders in exchange for 100% of the capital stock of CollabRx, Inc. Tegal and certain former CollabRx stockholders entered into a Stockholders Agreement providing for, among other things, registration rights, transfer restrictions and voting and standstill agreements. Tegal also assumed $500,000 of existing CollabRx indebtedness through the issuance of 5-year promissory notes in substitution for outstanding notes previously issued by CollabRx.
Tegal also announced financial results for the first quarter fiscal year 2013, which ended June 30, 2012. The Company’s net income (loss) per share in the first quarter of fiscal year 2013 was ($0.40), compared with ($0.59) in the first quarter of the prior fiscal year and $1.32.